Condition

Parkinson's Disease

Compensation

$50 per visit

Duration

10 weeks

Parkinson’s Disease with Psychosis

Official Title

Parkinson's Disease with Psychosis

Study Summary

A study to evaluate the safety and tolerability of SEP363856 in subjects with Parkinson's Disease Psychosis

Eligibility and Recruitment Information

Recruitment Status Recruiting
Eligible Genders Both
Eligible Ages 55-105
Inclusion Diagnosed with Parkinson's Disease and have been experiencing symptoms of psychosis. Symptoms of psychosis include, delusions (false beliefs) and hallucinations (seeing or hearing things that others do not see or hear); Stable dose of Carbidopa/Levodopa and have not failed more than two antipsychotics.
Exclusion Subject has psychosis secondary to other toxic or metabolic disorders.
Start Date
Compensation $50 per visit
Location Orlando, FL

Study Information

Condition Parkinson's Disease
Study Phase Phase 2

Administrative Information

Study ID NCT02969369
Investigators Ira Goodman, MD

Apply for this study

Please include your first name.
Please include your last name.
Please include a valid email address.
loading
Thank you for applying.
Sorry, something wen't wrong. Please contact us for support.